📊 TBI Key Takeaways
Is TrueBlue, Inc. (TBI) a Good Investment?
TrueBlue is operationally unprofitable with negative free cash flow of -$12.6M, creating an unsustainable financial position despite modest 3.1% revenue growth. While EPS has improved 61.4% year-over-year, the company remains deeply unprofitable with negative operating margins (-4.5%) and is burning cash operationally, indicating fundamental business challenges that must be resolved for long-term viability.
Why Buy TrueBlue, Inc. Stock? TBI Key Strengths
- Modest revenue growth of 3.1% YoY demonstrates maintained market demand
- Strong liquidity position with current ratio of 2.09x enables near-term obligation coverage
- Moderate leverage with debt-to-equity of 0.29x provides balance sheet stability
TBI Stock Risks: TrueBlue, Inc. Investment Risks
- Unprofitable operations with negative operating margin (-4.5%) and net margin (-5.0%)
- Negative free cash flow of -$12.6M indicates business is burning cash despite positive revenue
- Negative return on equity (-7.7%) and return on assets (-3.2%) showing value destruction
- Low cash position ($24.1M) relative to total liabilities ($364.6M) limits financial flexibility
- Negative interest coverage ratio (-5.7x) indicates inability to service debt from operating income
Key Metrics to Watch
- Operating cash flow trajectory - critical to assess if operations can sustain business model
- Gross margin improvement trend - indicates if operational efficiency gains are being achieved
- Path to profitability and operating leverage - management's timeline and strategy for return to positive net income
TrueBlue, Inc. (TBI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.09x current ratio provides a solid financial cushion.
TBI Profit Margin, ROE & Profitability Analysis
TBI vs Services Sector: How TrueBlue, Inc. Compares
How TrueBlue, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is TrueBlue, Inc. Stock Overvalued? TBI Valuation Analysis 2026
Based on fundamental analysis, TrueBlue, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
TrueBlue, Inc. Balance Sheet: TBI Debt, Cash & Liquidity
TBI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: TrueBlue, Inc.'s revenue has declined by 20% over the 5-year period, indicating business contraction. The most recent EPS of $-0.45 indicates the company is currently unprofitable.
TBI Revenue Growth, EPS Growth & YoY Performance
TBI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $370.3M | -$14.3M | $-0.48 |
| Q3 2025 | $382.4M | -$1.9M | $-0.06 |
| Q2 2025 | $396.2M | -$160.0K | $-0.01 |
| Q1 2025 | $370.3M | -$1.7M | $-0.05 |
| Q3 2024 | $382.4M | -$10.0K | $0.00 |
| Q2 2024 | $396.2M | -$7.3M | $-0.24 |
| Q1 2024 | $402.9M | -$1.7M | $-0.05 |
| Q3 2023 | $473.2M | -$10.0K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
TrueBlue, Inc. Dividends, Buybacks & Capital Allocation
TBI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for TrueBlue, Inc. (CIK: 0000768899)
📋 Recent SEC Filings
❓ Frequently Asked Questions about TBI
What is the AI rating for TBI?
TrueBlue, Inc. (TBI) has an AI rating of SELL with 78% confidence, based on fundamental analysis of SEC EDGAR filings.
What are TBI's key strengths?
Claude: Modest revenue growth of 3.1% YoY demonstrates maintained market demand. Strong liquidity position with current ratio of 2.09x enables near-term obligation coverage.
What are the risks of investing in TBI?
Claude: Unprofitable operations with negative operating margin (-4.5%) and net margin (-5.0%). Negative free cash flow of -$12.6M indicates business is burning cash despite positive revenue.
What is TBI's revenue and growth?
TrueBlue, Inc. reported revenue of $398.6M.
Does TBI pay dividends?
TrueBlue, Inc. does not currently pay dividends.
Where can I find TBI SEC filings?
Official SEC filings for TrueBlue, Inc. (CIK: 0000768899) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is TBI's EPS?
TrueBlue, Inc. has a diluted EPS of $-0.66.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is TBI a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, TrueBlue, Inc. has a SELL rating with 78% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is TBI stock overvalued or undervalued?
Valuation metrics for TBI: ROE of -7.7% (sector avg: 16%), net margin of -5.0% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy TBI stock in 2026?
Our dual AI analysis gives TrueBlue, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is TBI's free cash flow?
TrueBlue, Inc.'s operating cash flow is $-9.8M, with capital expenditures of $2.8M. FCF margin is -3.2%.
How does TBI compare to other Services stocks?
Vs Services sector averages: Net margin -5.0% (avg: 10%), ROE -7.7% (avg: 16%), current ratio 2.09 (avg: 1.5).